Kirsten Karberg

Möhrendorfer Str. 1c
Erlangen, BY 91056, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Rheumatological care of older people : Annual report 2026 from the National Database of the regional Collaborative Arthritis Centers

Rheumatological care of older people : Annual report 2026 from the National Database of the regional Collaborative Arthritis Centers

Journal: Zeitschrift fur Rheumatologie

Published: May 13, 2026

Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA Register.

Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA Register.

Journal: RMD open

Published: September 12, 2025

Trends in fatigue in inflammatory rheumatic diseases: Annual data and trajectory analysis of the German National Database 2007-2023.

Trends in fatigue in inflammatory rheumatic diseases: Annual data and trajectory analysis of the German National Database 2007-2023.

Journal: Seminars in arthritis and rheumatism

Published: September 08, 2025

Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry

Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry

Journal: Zeitschrift fur Rheumatologie

Published: June 18, 2025

Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review.

Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review.

Journal: Frontiers in medicine

Published: April 23, 2025

Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis.

Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis.

Journal: Rheumatology international

Published: April 17, 2025

Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany

Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany

Journal: Zeitschrift fur Rheumatologie

Published: March 13, 2025

RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.

RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.

Journal: Rheumatology international

Published: January 07, 2025

Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Journal: Rheumatology international

Published: October 21, 2024

Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.

Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.

Journal: Frontiers in immunology

Published: June 07, 2024

Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.

Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.

Journal: Rheumatology international

Published: March 31, 2024

Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database.

Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database.

Journal: Frontiers in immunology

Published: March 04, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026